Amgen Inc AMGN Sustained Biotech Sector Outperformance Backed by MoatLike Competitive Advantages LPTH LightPath Technologies gains 10 percent in daily trading even as Q1 2026 earnings sharply miss analyst expectations CIM Chimera reports Q4 2025 earnings per share above analyst projections stock registers mild daily gains